Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
0.201
-0.003 (-1.67%)
Apr 29, 2026, 9:19 AM EDT - Market open
Liminatus Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -10.21 | -3.55 | -4.98 | -2.93 | -5.61 |
| Depreciation & Amortization | 0 | - | - | - | 0 |
| Asset Writedown & Restructuring Costs | - | - | - | 0.9 | 0.9 |
| Other Operating Activities | 7.23 | - | - | - | 1.5 |
| Change in Accounts Payable | -4.04 | -0.01 | 0.43 | 0.09 | 0.04 |
| Change in Other Net Operating Assets | -2.95 | 2.11 | 1.21 | 1.07 | 3.01 |
| Operating Cash Flow | -9.96 | -1.45 | -3.35 | -0.87 | -0.17 |
| Capital Expenditures | -0.01 | - | - | - | - |
| Investing Cash Flow | -0.79 | -2.85 | -0.82 | - | - |
| Short-Term Debt Issued | 4.34 | 3.92 | 3.41 | 9.44 | - |
| Total Debt Issued | 4.34 | 3.92 | 3.41 | 9.44 | - |
| Short-Term Debt Repaid | -1.3 | - | -3.86 | -7.03 | - |
| Total Debt Repaid | -1.3 | - | -3.86 | -7.03 | - |
| Net Debt Issued (Repaid) | 3.04 | 3.92 | -0.45 | 2.42 | - |
| Issuance of Common Stock | 10.56 | - | - | 4.2 | - |
| Repurchase of Common Stock | - | - | - | -0.7 | - |
| Other Financing Activities | -2.56 | - | - | - | - |
| Financing Cash Flow | 11.03 | 3.92 | -0.45 | 5.92 | - |
| Net Cash Flow | 0.28 | -0.38 | -4.61 | 5.05 | -0.17 |
| Free Cash Flow | -9.98 | -1.45 | -3.35 | -0.87 | -0.17 |
| Free Cash Flow Per Share | -0.42 | -0.08 | -0.03 | -0.02 | - |
| Cash Interest Paid | - | - | - | 0.5 | - |
| Levered Free Cash Flow | 7.14 | -2.92 | -2.3 | -0.67 | - |
| Unlevered Free Cash Flow | 7.28 | -2.71 | -2.19 | -0.53 | - |
| Change in Working Capital | -6.98 | 2.1 | 1.64 | 1.16 | 3.05 |
Source: S&P Capital IQ. Standard template.
Financial Sources.